Viewing Study NCT04622761

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 12:32 PM

Ignite Modification Date: 2025-12-29 @ 12:09 AM

Study NCT ID: NCT04622761

Status: NOT_YET_RECRUITING

Last Update Posted: 2021-01-05

First Post: 2020-09-29

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome

Sponsor: The Clatterbridge Cancer Centre NHS Foundation Trust

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module